Elimination of Leprosy

Traveling man: the Goodwill Ambassador shares a joke with two residents of a leprosarium in Krantau, Uzbekistan during a visit in 2013.By External SourceMay 29 2020 (IPS-Partners)   Warm greetings from Sasakawa Health Foundation in Tokyo. The 100th Issue of the WHO Goodwill Ambassador’s Newsletter has been published. Read special interviews with the Goodwill Ambassador and the UN Special Rapporteur on leprosy, and check out the Timeline of all that has happened since the first issue. My Journey Continues I started this newsletter in April 2003 to share information about the fight against leprosy. This marks the 100th issue. Over the years I have reported my views on leprosy elimination and activities taking place around the world. As I write, we are in the grip of the COVID-19 pandemic. I commend the tireless efforts of medical personnel and hope the outbreak will be contained as quickly as possible. As Goodwill Ambassador I have visited some 100 countries and attach particular importance to three points: 1) going to see the situation for myself, listening directly to what people have to say and clarifying what the issues are; 2) making use of newspapers, TV, radio, social and other media to communicate correct information about the disease to people around the world; and 3) meeting with presidents and prime ministers to persuade them to actively tackle leprosy. My motto is “knowledge and practice go together.” While I respect the insights and informa...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Health Source Type: news

Related Links:

Patient´s perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice. J Dermatolog Treat. 2020 Jul 09;:1-9 Authors: Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Polo-Rodríguez I, Piteiro-Bermejo AB, Herrero-Fernández M, Arévalo-Serrano J, Trasobares-Marugán L, Medina-Montalvo S PMID: 32643475 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Authors: Okeke CAV, Shipman WD, Perry JD, Kerns ML, Okoye GA, Byrd AS PMID: 32643464 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
This story is available as part of a content partnership with WFAA-TV. For more local news, visit WFAA.com. Gov. Greg Abbott said that if recent closures and face mask requirements don't lead to better results in the state's fight in the coronavirus pandemic "additional action will be required." In an interview Friday afternoon with WFAA, Abbott said those measures, such as closing bars and other enfor cement, should lead to positive results. "If instead, we see the further explosion in the number…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
CONCLUSION: Adjuvant effect of CXL was significant in treating fungal keratitis compared to standalone antifungal treatment. PMID: 32644867 [PubMed - as supplied by publisher]
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
Authors: Multani PK, Modi R, Basu S Abstract PURPOSE: To investigate recurrence patterns following anti-tubercular therapy (ATT) in different anatomical presentations of ocular tuberculosis (OTB). METHODS: Retrospective analysis of clinically diagnosed OTB patients divided anatomically into groups A (anterior + intermediate uveitis) and B (posterior + panuveitis). Recurrence was defined as reappearance of intraocular inflammation in a quiescent eye following completion of at least 6-months ATT. Anatomical sites of recurrence were compared to that of presentation. RESULTS: No significant difference in post-A...
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
Authors: Agrawal R, Gunasekeran DV, Xu Y, Leo YS, Ng OT, Wong CS, Testi I, Ding J, Banu I, Teoh SC Abstract PURPOSE: To explore the all-cause mortality in patients with acquired immune deficiency syndrome (AIDS) and Cytomegalovirus (CMV) retinitis. METHODS: A retrospective cohort study of patients with CMV retinitis (CMVR) presented to a tertiary referral center in Singapore from January 1, 2004, through December 31, 2015. RESULTS: A total of 144 patients were studied (87 survived, 11 lost to follow up, 46 died). Patients with bilateral CMVR and six-month follow up CD4 + T cell count 50 cells/mm3 (p
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
CONCLUSION: Definite diagnosis of unilateral choroidal effusion was done. A comprehensive workup is needed to exclude potential malignant process. PMID: 32644830 [PubMed - as supplied by publisher]
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
Authors: Fu T, Deng M, Wang X, Yang F PMID: 32643980 [PubMed - as supplied by publisher]
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
CONCLUSIONS: A reduction in ERCP referrals raises concern that a cohort of patients with significant biliary disease remain undetected. Whether this results in later, and more severe, presentation remains to be seen but a potential surge in such cases could significantly burden all future endoscopy planning services. PMID: 32643467 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
San Quentin prison in US hasseven deaths and 1,500 positive tests; Serbia has record 18 fatalities; Australiacaps incoming flights and charges for quarantine8.22amBSTGood evening, good afternoon, good morning.This isDamien Gayle in London taking you through the next few hours of coronavirus-related updates and headlines from around the world.8.14amBSTI will be handing the blog over to my colleagues in the UK now. Thank you for following us here in Sydney and Melbourne today. Here is a wrap of the day so far:Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news Infectious diseases Science Source Type: news
More News: Brazil Health | Budgets | COVID-19 | Disability | Ethiopia Health | Eyes | HIV AIDS | Hypermetropia (long sighted) | India Health | Indonesia Health | International Medicine & Public Health | Leprosy | Malaria | Outbreaks | Pandemics | Philippines Health | Tuberculosis | Uzbekistan Health